Cerebrovascular Disease
📧 Sign up to get email alerts when something new happens for Cerebrovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Magnetic Resonance Imaging Studies of Motor and Thought Processes
This clinical trial update covers MRI studies of motor and thought processes conducted in participants with cerebrovascular disease, movemen…
-
CLINICAL_TRIALS trial_result · 2008-01-30Clinical Trial Update: Effects of Exercise on Endothelial Function in Stroke Patients [NA]
A clinical trial update examining the effects of exercise on endothelial function in stroke patients.
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Changes in Cerebrovascular Reactivity During Cognitive Activation After Cardiopulmonary Bypass: Relation With Intraoperative Embolic Load and Postoperative Neuropsychological Dysfunctions [NA]
This completed clinical trial update examines how cerebrovascular reactivity during cognitive tasks changes after cardiopulmonary bypass and…
-
CLINICAL_TRIALS trial_result · 2007-12-17Clinical Trial Update: Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
This clinical trial update reports on the efficacy of rosuvastatin in untreated high-risk patients in daily practice (CHALLENGE), with the s…
-
CLINICAL_TRIALS trial_result · 2007-11-26Clinical Trial Update: Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke [Phase 2]
A Phase 2 trial evaluating DP-b99 for neurological outcomes in acute ischemic hemispheric stroke has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-04-30Clinical Trial Update: RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease [Phase 2]
Phase 2 clinical trial update of rifalazil in Chlamydia pneumoniae seropositive patients with a history of atherosclerotic disease, evaluati…